Concepedia

Author

MaryAnn M. Murakami

Hennepin County Medical Center

Also Known As

MaryAnn M Murakami, MaryAnn M. Murakami

10

Publications

1.2K

Citations

9

H-Index

19

Concepts

All Affiliations

Hennepin County Medical CenterUniversity of MinnesotaBiostatistical Consulting (United States)
MM

About

MaryAnn M. Murakami is an author at Hennepin County Medical Center specializing in medicine, cardiovascular imaging, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

218

2

Public Health

3

3

186

3

Epidemiology

2

2

57

4

Emergency Medicine

1

1

35

5

Medical Laboratory Science

1

1

32

MaryAnn M. Murakami

×

8

Publications

1.1K

Citations

8

H-Index

YearCitations

Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease

Fred S. Apple, MaryAnn M. Murakami, Lesly A. Pearce,

Circulation

2002

557

Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death

Fred S. Apple, MaryAnn M. Murakami, Lesly A. Pearce,

Clinical Chemistry

2004

237

Cardiac Troponin I and T Alterations in Dog Hearts With Myocardial Infarction: Correlation With Infarct Size

Vincent Ricchiuti, Scott W. Sharkey, MaryAnn M. Murakami,

American Journal of Clinical Pathology

1998

129

Rates of Positive Cardiac Troponin I and Creatine Kinase MB Mass among Patients Hospitalized for Suspected Acute Coronary Syndromes

Joseph Lin, Fred S. Apple, MaryAnn M. Murakami,

Clinical Chemistry

2004

74

Increased Cardiac Troponin I As Measured by a High-Sensitivity Assay Is Associated with High Odds of Cardiovascular Death: The Minnesota Heart Survey

Fred S. Apple, Lyn M. Steffen, Lesly A. Pearce,

Clinical Chemistry

2012

56

Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay

Fred S. Apple, Stephen W. Smith, Lesly A. Pearce,

Clinical Biochemistry

2012

35

Multi-center validation of the Response Biomedical Corporation RAMP® NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys® proBNP assay

Elizabeth Lee-Lewandrowski, James L. Januzzi, Sandy M. Green,

Clinica Chimica Acta

2007

32

Use of the bioMérieux VIDAS® troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome

Fred S. Apple, Stephen W. Smith, Lesly A. Pearce,

Clinica Chimica Acta

2008

22

Page 1